| Identification | Back Directory | [Name]
MAGNESIUM LITHOSPERMATE B 98% | [CAS]
122021-74-3 | [Synonyms]
Monomethyl lithospermate B
magnessium lithospermate B
MAGNESIUM LITHOSPERMATE B 98%
magnesium,2-[(E)-3-[3-[1-carboxylato-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydro-1-benzofuran-4-yl]prop-2-enoyl]oxy-3-(3,4-dihydroxyphenyl)propanoate | [Molecular Formula]
C36H28MgO16 | [MDL Number]
MFCD00914300 | [MOL File]
122021-74-3.mol | [Molecular Weight]
740.903 |
| Chemical Properties | Back Directory | [solubility ]
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | [form ]
Powder | [color ]
Light yellow to light brown | [Cosmetics Ingredients Functions]
SKIN PROTECTING
ANTIMICROBIAL
ANTIOXIDANT
HUMECTANT
HAIR CONDITIONING | [InChIKey]
ANUBYMNVOPVATP-OAZHBLANSA-L |
| Hazard Information | Back Directory | [Uses]
Magnesium Lithospermate B, is a derivative of caffeic acid tetramer and an inhibitor of Na+/K+ ATPase, which can be extracted from Salviae miltiorrhizae. Magnesium Lithospermate B is widely used for the research of cardiovascular diseases, and it can protect against glucose-induced intracellular oxidative damage. Magnesium Lithospermate B also suppresses neuroin?ammation and attenuates neurodegeneration[1][2][3]. | [in vivo]
Magnesium Lithospermate B (2-8 mg/kg; p.o. once daily for 16 d) reduces the renal damage of oxidative stress through reduction of reactive oxygen species in old rats[1].
Magnesium Lithospermate B (0.5 μg/g; s.c. for 6 weeks) promotes the neurogenesis and improves the memory in PD models[3]. | Animal Model: | Young (5-month-old) and old (20-month-old) specific-pathogen-free male Sprague-Dawley rats[1] | | Dosage: | 2, 8 mg/kg | | Administration: | P.o. once daily for 16 days | | Result: | Reduced the protein expression of major subunits of nicotinamide adenine dinucleotide phosphate oxidase (Nox4 and p22phox), phospho-p38, nuclear factor-kappa B p65, cyclooxygenase-2, and inducible nitric oxide synthase.
Showed lower levels of senescence-related proteins such as p16, ADP-ribosylation factor 6, p53, and p21.
|
| [target]
p65 | NF-kB | TGF-β/Smad | ROS | PDGFR | [References]
[1] Magnesium lithospermate B possesses inhibitory activity on Na+,K+‐ATPase and neuroprotective effects against ischemic stroke
[2] Park CH, et, al. Magnesium Lithospermate B from Salvia miltiorrhiza Bunge Ameliorates Aging-Induced Renal Inflammation and Senescence via NADPH Oxidase-Mediated Reactive Oxygen Generation. Phytother Res. 2017 May;31(5):721-728. DOI:10.1002/ptr.5789
[3] Quan W, et, al. Antioxidant properties of magnesium lithospermate B contribute to the cardioprotection against myocardial ischemia/reperfusion injury in vivo and in vitro. J Tradit Chin Med. 2013 Feb; 33(1): 85-91. DOI:10.1016/s0254-6272(13)60106-5
[4] Zhang Z, et, al. Magnesium lithospermate B promotes proliferation and differentiation of neural stem cells in vitro and enhances neurogenesis in vivo. Tissue Cell. 2018 Aug; 53:8-14. DOI:10.1016/j.tice.2018.05.012 |
|
|